Institutional members access full text with Ovid®

Share this article on:

Epidemiology of Human Immunodeficiency Virus, Viral Hepatitis (B and C), Treponema pallidum, and Human T-Cell Lymphotropic I/II Virus Among Men Who Have Sex With Men in Buenos Aires, Argentina

Pando, María A. PhD*; Bautista, Christian T. MSc; Maulen, Sergio MD; Duranti, Ricardo MD; Marone, Ruben BS; Rey, Jorge MD§; Vignoles, Moira BS*; Eirin, Maria E. BS*; Biglione, Mirna M. MD, PhD*; Griemberg, Gloria BS; Montano, Silvia M. MD, MPH; Carr, Jean K. MHS, PhD**; Sanchez, José L. MD, MPH††; Ávila, María M. PhD*

Sexually Transmitted Diseases: May 2006 - Volume 33 - Issue 5 - p 307-313
doi: 10.1097/01.olq.0000194578.06795.2d
Article

Background: Human immunodeficiency virus (HIV) and sexually transmitted infections (STI) are prevalent among men who have sex with men (MSM).

Goal: To estimate the prevalence of HIV and STIs in this group.

Study: A total of 694 MSM were tested for HIV, hepatitis B (HBV), hepatitis C (HCV), human T-cell lymphotropic (HTLV-I/II) viruses and Treponema pallidum infection.

Results: HIV, HBV, and T pallidum were detected in 13.8%, 37.7%, and 16.9% of subjects, respectively. Prevalences of 1.9% and 0.3% were detected for HCV and HTLV-I/II. A prior history of STI was the most predictor for HIV, HBV, and T pallidum. Use of illegal drugs, blood transfusion history, and multiple sexual partners were associated with HCV. The 2 most common coinfections were HBV/T pallidum and HIV/HBV.

Conclusions: Infection with HIV, HBV, and T pallidum was elevated among MSM. Routine testing, education, vaccine-based prevention, and control programs need to be implemented in this high-risk population.

A cross-sectional study of 694 men who have sex with men was conducted in Buenos Aires, Argentina, to estimate the prevalence of human immunodeficiency virus (HIV) and sexually transmitted infections. This study showed a high prevalence of hepatitis B (37.7%), Treponema pallidum, (16.9%), and HIV (13.8%).

From the *Centro Nacional de Referencia para el SIDA, Departamento de Microbiología, Parasitología e Inmunología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina; †US Military HIV Research Program at the Walter Reed Army Institute of Research, the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Rockville, Maryland; ‡Nexo, Asociación Civil, Buenos Aires, Argentina; §Laboratorio de Hemoterapia, Hospital de Clínicas “José de San Martín,” Buenos Aires, Argentina; ∥Laboratorio de Inmunología Clínica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina; the ¶US Naval Medical Research Center Detachment, Lima, Perú; **Division of Epidemiology, Institute of Human Virology, University of Maryland Biotechnology Institute, Baltimore, Maryland; and ††Anteon Corporation, Frederick, Maryland

The authors want to thank Wiener Laboratorios of Rosario, Argentina, for the supply of the reagents used for HBV and HCV diagnosis, as well as the technical assistance provided by Sebastian A.

Financial Support: This study was supported by the US Military HIV Research Program at the Walter Reed Army Institute of Research, Rockville, MD, (WRAIR 914) and by the US Naval Medical Research Command, Silver Spring, MD (Work Unit No. 62787A 873 H B0002).

Correspondence: María M. Avila, PhD, Centro Nacional de Referencia para el SIDA, Departamento de Microbiología, Parasitología e Inmunología, Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, Piso 11, C1121ABG, Buenos Aires, Argentina. E-mail: mavila@fmed.uba.ar.

Human Use Statement: The study was approved by institutional review boards and scientific ethical committees at the University of Buenos Aires, at the US Naval Medical Research Center, and at the Walter Reed Army Institute of Research in the United States.

Disclaimer: The opinions and assertions contained herein do not reflect the official position of the Argentinean Ministry of Health, of the Department of Defense, of the US Department of the Navy or Army, of the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., or of Anteon Corporation.

Portions of the results contained in this manuscript have been presented at the XIV International AIDS Conference, July 2002, Barcelona, Spain (Abstract ThPeC7526); at the 8th World STI/AIDS Congress, December 2003, Punta del Este, Uruguay (Abstract 349); and at the XV International AIDS Conference, July 2004, Bangkok, Thailand (Abstract C12256).

Conflicts of interest: none reported.

© Copyright 2006 American Sexually Transmitted Diseases Association